Liberty Health Sciences (OTCMKTS:LHSIF) Stock Price Down 2.2% – Time to Sell?

Liberty Health Sciences Inc. (OTCMKTS:LHSIF)’s stock price fell 2.2% during trading on Monday . The stock traded as low as $1.10 and last traded at $1.1446. 671,400 shares were traded during trading, a decline of 60% from the average session volume of 1,668,884 shares. The stock had previously closed at $1.17.

Liberty Health Sciences Stock Performance

The stock has a market capitalization of $392.01 million, a P/E ratio of 38.17 and a beta of 1.70. The business has a 50-day moving average price of $1.14 and a 200 day moving average price of $1.14.

About Liberty Health Sciences

Liberty Health Sciences, trading on the OTC Markets under the symbol LHSIF, is a vertically integrated medical cannabis company headquartered in Florida. The company holds state‐issued Medical Marijuana Treatment Center licenses that authorize cultivation, processing and retail operations within Florida’s regulated medical marijuana program. Its state‐of‐the‐art cultivation facilities feature controlled indoor and greenhouse environments designed to produce consistent, high‐quality flower and derivative products.

Liberty Health Sciences markets its products under the Sunshine Cannabis Co brand, offering a range of cannabis formulations that include dried flower, pre-rolled joints, concentrates, oils, capsules and topical preparations.